「sse」の検索結果

Use when a task needs the judgment of an Electromechanical Equipment Assembler — verifying shaft/coupling alignment directly rather than trusting an initial functional test that only confirms the device runs, applying fastener torque to spec with a calibrated tool rather than by feel, routing wire to account for the equipment's full range of motion rather than its static assembled position, or distinguishing electrical from mechanical root cause when a device malfunctions.

日本語の概要は準備中です。原文の説明を表示しています。

Assess the scientific integrity and trustworthiness of publications before relying on their findings. Use this skill whenever evaluating a paper for a workflow, citing a study, building an analysis on published methods, or when a user asks about the reliability of a study. Checks for formal retractions, corrections, expressions of concern, and — critically — informal contradictions where subsequent studies failed to reproduce key findings. Integrates with PubMed, bioRxiv, and Consensus to provide a trust assessment. Use this skill for ANY publication evaluation, retraction checking, author reliability assessment, or when a user says "can I trust this paper", "is this study reliable", "has this been refuted", or "check this publication".

日本語の概要は準備中です。原文の説明を表示しています。

JLCPCB PCB fabrication and assembly — BOM/CPL generation, basic vs extended parts, assembly constraints, design rules, ordering workflow. Use with KiCad for JLCPCB manufacturing. Use this skill when the user mentions JLCPCB, wants to order PCBs or assembled boards, needs prototype bare PCBs and stencils, wants to know JLCPCB design rules and capabilities, or is asking about PCB manufacturing costs or turnaround times. For gerber/CPL export, stencil ordering, and BOM management, see the `bom` skill.

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes asset lifecycle planning systems for capital expenditure forecasting, replacement scheduling, total cost of ownership modeling, depreciation tracking, and facility condition assessments using IFMA standards and Facility Condition Index scoring..

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill to configure SLA enforcement for Salesforce Field Service (FSL) using Work Order entitlement processes: designing entitlement processes of type Work Order, defining FSL milestones (response time, on-site arrival, resolution), wiring milestone actions, and aligning Business Hours with service territory Operating Hours. NOT for Case SLAs and Case entitlement processes — use admin/entitlements-and-milestones. NOT for defining the SLA tier table and escalation matrix — use architect/sla-design-and-escalation-matrix.

日本語の概要は準備中です。原文の説明を表示しています。

Whole site or product — a full web accessibility (a11y) audit against WCAG 2.2, following the WCAG-EM methodology. Defines scope, samples representative pages and flows, runs the automated tier (`accessibility-scan`) and the hands-on manual tier (`accessibility-inspect`), and produces one conformance report. Grades each finding by severity and evidence basis, and states per-criterion conformance as pass, fail, or undetermined (needs a human). Use it for 'audit my site for accessibility', 'is this product accessible', 'a11y audit', 'WCAG or Section 508 conformance report', or any multi-page assessment. Assesses; does not fix (use `accessibility-fix`) or diff (use `accessibility-diff`). For a single page use `accessibility-scan`; for hands-on keyboard and screen-reader checks use `accessibility-inspect`.

日本語の概要は準備中です。原文の説明を表示しています。

Write, audit, or improve an iOS App Store listing — app name, subtitle, keyword field, screenshots, app icon, preview video, creative assets, tags, ratings strategy, localization, and featuring nominations. Use when creating or reviewing App Store metadata, doing keyword research, planning a metadata update, or when the user mentions ASO, App Store Optimization, app store listing, keywords, subtitle, screenshot captions, preview video, app icon, Liquid Glass, creative assets, product page header, search results creative, Asset Library, featuring, ratings prompt, or Apple Ads.

日本語の概要は準備中です。原文の説明を表示しています。

Deploy smart contracts and bridge assets to Abstract (ZK Stack L2). Use when an agent needs to deploy contracts on Abstract, bridge ETH/tokens to Abstract, trade/swap tokens, check balances, transfer assets, or interact with Abstract mainnet. Covers zksolc compilation, Hardhat deployment, Relay bridging, DEX trading, and key contract addresses.

日本語の概要は準備中です。原文の説明を表示しています。

Deploy smart contracts and bridge assets to Abstract (ZK Stack L2). Use when an agent needs to deploy contracts on Abstract, bridge ETH/tokens to Abstract, trade/swap tokens, place predictions on Myriad Markets, check balances, transfer assets, or interact with Abstract mainnet. Covers zksolc compilation, Hardhat deployment, Relay bridging, DEX trading (Kona, Aborean), Myriad prediction markets, and key contract addresses.

日本語の概要は準備中です。原文の説明を表示しています。

分布式并行策略选型与实测（USP / CP 通信掩盖 / CFG / TP/RSP/PP 概览；含拓扑相关选型 （按实测拓扑分域条件化：域内 bulk vs 跨域 head-parallel 翻转）与 AlltoAllV 缺陷绕过）。在 model-auto-optimization 中承担 S3：优先 USP、结合拓扑带宽差异选 CP，少量 step + 多 rank 验证特性开启与掩盖（产物：并行方案 + 多 rank 证据）。当用户需要多卡并行 策略选择、**序列并行形态抉择**（纯 Ulysses vs 复合 AllGather-KV×Ulysses：按 GQA / 跨域带宽 / 形态 plumbing 条件化定胜负）、**并行 × 稀疏叠加**（seam 契约：先汇聚后稀疏、 窗口偏移、块对齐、per-head 掩码；含「稀疏看似生效实则未生效」判定）、通信掩盖调优 （含**掩盖率上限**：1-1/n 何时成立、c/f 决定的真实上限、没生效的排查）、**并行方案 差异归因**（阶段 Δ 分解 / 集合通信按 communicator 归属 / 4→8 卡线性度），或排查多卡 跑不动 / 通信暴露大 / 换卡组 / 端口 bind / HCCL 带宽验证问题时使用；**并收编原并行作用域诊断**： 改了 SP/CP/Ulysses/AllGather-KV 后**不报错但结果没变/性能没变**、或小规模能跑大规模崩 （如 Ascend EE1003 coreDim 超限）时，用本技能证明"改动到底有没有生效"（判别量逐层收窄 + 两侧对照 + 日志≠生效，见 `references/scope-effectiveness-check.md`）； 即使用户只说 "多卡跑不动""通信暴露大""为什么没达到 6/7 的掩盖率""CP 和 USP 该选哪个""CP 叠稀疏 怎么不生效"而未说并行，也应触发。特性档位/接口事实见 `docs/zh/features/parallelism.md` /`usp.md`（仓内真源），框架侧开启见 framework-integration； 本技能承载选型决策、monkey-patch 掩盖与多卡诊断实测。 由 dev-workflow 多卡场景触发，亦由 model-auto-optimization 的 S3 阶段触发。

日本語の概要は準備中です。原文の説明を表示しています。

Produces internal case viability and conflict check memos for personal injury litigation intake. Screens conflicts, assesses liability and damages, checks statute of limitations, and outputs an accept/decline recommendation. Use when evaluating new PI intake, running conflict checks, assessing case merit pre-filing, or preparing acceptance memos.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a Bill of Sale, Assignment and Assumption Agreement for M&A asset purchase closings. Transfers purchased assets (tangible and intangible) from seller to buyer and memorializes assumption of specified liabilities. Use when drafting closing deliverables for asset purchase transactions, including IP assignments, contract rights transfers, and goodwill conveyances.

日本語の概要は準備中です。原文の説明を表示しています。

Produces structured asset and liability summaries from financial documents for legal proceedings. Extracts valuations, ownership classifications, and encumbrances, then outputs net-worth overview, categorized schedules, disputed items, and documentation gaps. Use when preparing financial summaries for divorce/dissolution, estate planning, bankruptcy, business valuation, or settlement negotiations. Trigger on: net worth summary, marital estate, balance sheet, asset schedule, liability schedule, community/separate property.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a U.S. asset purchase letter of intent (LOI) separating binding from non-binding terms and capturing deal points, diligence, exclusivity, and closing path. Trigger on "letter of intent", "LOI", "asset purchase", "M&A LOI", "no-shop", "exclusivity", "purchase price", "due diligence".

日本語の概要は準備中です。原文の説明を表示しています。

Produces litigation-grade case summaries for animal law disputes including cruelty/neglect prosecutions, ownership/custody, dangerous animal designations, veterinary malpractice, and service/assistance animal accommodations. Builds exhibit-cited factual timelines, maps evidence to statutory elements, evaluates expert evidence, and assesses remedies with jurisdiction-specific legal research. Use when summarizing animal law cases, analyzing animal cruelty charges, pet custody disputes, dangerous dog hearings, veterinary malpractice claims, or assistance animal accommodation matters. Also trigger for animal forfeiture, bite liability, wildlife possession, or animal-related court filings.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill to generate well-branded interfaces and assets for MeowKit (AI Agent Toolkit for Claude Code), either for production or throwaway prototypes/mocks/etc. Contains essential design guidelines, colors, type, fonts, assets, and UI kit components for prototyping.

日本語の概要は準備中です。原文の説明を表示しています。

Aesthetic assessment and design scoring across 6 dimensions. Use for UI critique, design review, visual quality assessment, remix suggestions. Activate on "design critique", "aesthetic review", "UI assessment", "visual quality", "design score", "remix this design". NOT for implementation (use frontend-developer), accessibility-only audits (use color-contrast-auditor), or brand identity creation.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses the quality and completeness of a genome annotation with BUSCO (conserved single-copy ortholog recovery), OMArk (proteome completeness, consistency, and contamination), CheckM2 (prokaryotic completeness/contamination), and a gene-set sanity panel (gene count, mono-exonic fraction, protein-length distribution, mRNA:gene ratio, coding density). Covers the assembly-BUSCO-vs-proteome-BUSCO diagnostic, what BUSCO-Duplicated really means, why gene count is a vanity metric, and the QC of transferred annotations. Use when judging whether an annotation is good enough to publish or submit, diagnosing a suspect annotation, or comparing annotation completeness across pipelines.

日本語の概要は準備中です。原文の説明を表示しています。

Runs JACKS (Joint Analysis of CRISPR/Cas9 Knockout Screens; Allen et al 2019 Genome Research) which models per-sgRNA log-fold-change as the product of a treatment-dependent gene-essentiality term and a treatment-independent guide-efficacy term. Covers the Bayesian decomposition math, the hierarchical efficacy prior shared across screens performed with the same library, when JACKS outperforms MAGeCK (multi-screen joint analysis, libraries with broad efficacy variance) and when it does not (single screen, novel libraries with no prior efficacy), library-reuse efficacy transfer, downstream essentiality interpretation, and the 2.5x sample-size reduction enabled by efficacy-aware testing. Use when running multiple screens with the same library, when guide-level noise is suspected to dominate per-gene signal, when reusing published essentiality reference screens for efficacy priors, or when comparing screens performed across cell lines that share library but differ biologically.

日本語の概要は準備中です。原文の説明を表示しています。

Read, write, and index compressed sequence files (gzip, bzip2, xz, BGZF) with Biopython and bgzip/samtools. Use when working with .gz, .bz2, or .bgz sequence files, when random access into a compressed FASTA/FASTQ is needed, or when SeqIO.index/faidx/tabix rejects a plain .gz. Covers the BGZF-vs-gzip seekability asymmetry, the 'rt'-not-'rb' handle trap, virtual offsets, and gzip-to-BGZF conversion.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses that CGM low- and high-glucose alarm thresholds are individualized to optimize patient benefit and minimize alarm fatigue. Triggered by clinician prompts to 'Review low-glucose alarm thresholds' or 'Ensure alarms are individualized and not excessive'.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses the patient’s ability to prevent, detect, and treat hypoglycemia, including recognition of symptoms, appropriate carbohydrate treatment, and use of emergency glucagon. Triggered when clinicians review the hypoglycemia action plan or check whether the patient recognizes low symptoms and treatment steps.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses a patient’s ability to operate an insulin pump and make setting changes, evaluating dexterity, vision, mental health, and cognition for independent or assisted use. Triggered by phrases such as 'Check patient can manipulate pump controls' and 'Evaluate dexterity and vision for pump use'.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses patient’s understanding of how CGM data (trends, rates of change) differ from discrete SMBG fingerstick values. Triggered when clinicians hear requests to explain lag and trend arrows on CGM or teach the difference between CGM glucose and fingerstick glucose.

日本語の概要は準備中です。原文の説明を表示しています。